MULTIPLE MYELOMA (MM)
Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktails show promise in battling blood cancer
Disease control CompletedThis study tested different combinations of cancer drugs (carfilzomib, cyclophosphamide, lenalidomide, and dexamethasone) in 477 adults with newly diagnosed multiple myeloma who were eligible for a stem cell transplant. The goal was to see which combination worked best before and…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE2 • Sponsor: Mario Boccadoro • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Smart sequencing: fewer drugs, same results for myeloma?
Disease control CompletedThis study tested a new way to treat multiple myeloma by starting with only two drugs (bortezomib and dexamethasone) and adding a third drug (lenalidomide) only if the disease did not respond well. The goal was to see if this step-by-step approach could achieve the same good resu…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:40 UTC